BXP vs IRD · rev $3.48B vs rev $11.0M
Boston Properties Inc (BXP) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
BXP currently screens at market cap $12.12B. IRD currently screens at market cap $35.7M.
Not investment advice. Open the BXP and IRD stock pages for the full models.
Not investment advice.